To include your compound in the COVID-19 Resource Center, submit it here.

Mojave: The APCs of immunity

One reason cancers continue to grow despite normal immune surveillance is that cytotoxic T cells do not recognize tumor cells as foreign or cannot keep up with tumor cell growth. To address that issue, researchers have developed vaccines to boost the normal immune response to tumors. Heat shock proteins (Hsps) have been targeted by a number of groups, including Mojave Therapeutics Inc., as an immune stimulant that can act

Read the full 696 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers